Abstract
Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 33-39 |
| Number of pages | 7 |
| Journal | Journal of Clinical Psychiatry |
| Volume | 51 |
| Issue number | 1 SUPPL. |
| State | Published - 1990 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
- Clinical Psychology
Cite this
Psychopharmacology of depression in neurologic disorders. / Silver, J. M.; Hales, Robert E; Yudofsky, S. C.
In: Journal of Clinical Psychiatry, Vol. 51, No. 1 SUPPL., 1990, p. 33-39.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Psychopharmacology of depression in neurologic disorders
AU - Silver, J. M.
AU - Hales, Robert E
AU - Yudofsky, S. C.
PY - 1990
Y1 - 1990
N2 - Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.
AB - Depression occurs frequently in patients with neurologic disorders. Current research in traumatic brain injury, stroke, Parkinson's disease, multiple sclerosis, epilepsy, and brain tumors indicates that affective symptomatology can be a specific sequel of these illnesses that is related to the resultant impairment in brain functioning. Because of the cognitive and emotional deficits that neurologic disorders can cause, the clinician must be aware of the complicated presentation of depression in these patients. Psychopharmacologic treatments are safe and efficacious in the treatment of depression in patients with neurologic illness.
UR - http://www.scopus.com/inward/record.url?scp=0025129190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025129190&partnerID=8YFLogxK
M3 - Article
VL - 51
SP - 33
EP - 39
JO - Journal of Clinical Psychiatry
JF - Journal of Clinical Psychiatry
SN - 0160-6689
IS - 1 SUPPL.
ER -